Abstract
We investigated the effects of stearic acid (saturated), oleic acid (monounsaturated), linoleic acid (n−6 polyunsaturated), and α-linolenic acid (n−3 polyunsaturated) on lipid metabolism in a hepatocyte-derived cell line, HepG2. HepG2 cells were cultured in medium supplemented with either stearic acid (0.1% w/v), oleic acid (0.1% v/v), linoleic acid (0.1% v/v), or α-linolenic acid (0.1% v/v). After 24 h, expression of lipid metabolism-associated genes was evaluated by real-time PCR. α-Linolenic acid showed a suppressive effect on the hepatic fatty acid de novo synthesis and fatty acid oxidation pathways, while linoleic acid also showed a tendency to suppress these pathways although the effect was weaker. Moreover, α-linolenic acid enhanced the expression of enzymes associated with reactive oxygen species (ROS) elimination. In contrast, oleic acid tended to promote fatty acid synthesis and oxidation. In conclusion, α-linolenic acid and linoleic acid may be expected to ameliorate hepatic steatosis by downregulating fatty acid de novo synthesis and fatty acid oxidation, and by upregulating ROS elimination enzymes. Oleic acid had no distinct effects for improving steatosis or oxidative stress.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bucher H. C.; Hengstler P.; Schindler C.; Meier G. N−3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled study. Am J Med. 112: 298–304; 2002. doi:10.1016/S0002-9343(01)01114-7.
Burdge G. C. Metabolism of α-linolenic acid in humans. Prostaglandins Leukotrienes Essential Fatty Acids.161–168; 2006. doi:10.1016/j.plefa.2006.05.013.
El-Badry A. M.; Graf R.; Clavien P.-A. Omega 3–omega 6: what is right for the liverJ Hepatol.: 47: 718–725; 2007. doi:10.1016/j.jhep.2007.08.005.
Fujimoto Y.; Onoduka J.; Homma K. J. et al. Long-chain fatty acids induce lipid droplet formation in a cultured human hepatocyte in a manner dependent of Acyl-CoA synthetase. Biol Pharm Bull. 29: 2174–2180; 2006. doi:10.1248/bpb.29.2174.
Ghafoorunissa I. A.; Rajkumar L.; Acharya V. Dietary (n−3) long chain polyunsaturated fatty acids prevent sucrose-induced insulin resistance in rats. J Nutr. 135: 2634–2638; 2005.
Javadi M.; Geelen M. J.; Lemmens A. G. et al. The influence of dietary linoleic and alpha-linolenic acid on body composition and the activities of key enzymes of hepatic lipogenesis and fatty acid oxidation in mice.. J Anim Physiol Anim Nutr. 91: 11–18; 2007. doi:10.1111/j.1439-0396.2006.00636.x.
Kohjima M.; Enjoji M.; Higuchi N. et al. Re-evaluation of fatty acid metabolism-related gene expression in non-alcoholic fatty liver disease. Int J Mol Med. 20: 351–358; 2007.
Levy J. R.; Clore J. N.; Stevens W. Dietary n−3 poly unsaturated fatty acids decrease hepatic triglycerides in Fischer 344 rats. Hepatology. 39: 608–616; 2004. doi:10.1002/hep.20093.
Murase T.; Aoki M.; Tokimitsu I. Supplementation with α-linolenic acid-rich diacylglycerol suppresses fatty liver formation accompanied by an up-regulation of oxidation in Zucker fatty rats. Biochim Biophys Acta. 1733: 224–231; 2005.
Sanyal A. J.; Campbell-Sargent C.; Mirshahi F. et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 120: 1183–1192; 2001. doi:10.1053/gast.2001.23256.
Schmocker C.; Weylandt K. H.; Kahlke L. et al. Omega-3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines. Hepatology. 45: 864–869; 2007. doi:10.1002/hep.21626.
Sekiya M.; Yahagi N.; Matsuzaka T. et al. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology. 39: 608–616; 2003.
Stulnig T. M. Immunomodulation by polyunsaturated fatty acids; mechanisms and effects. Int Arch Allergy immunol. 132: 310–321; 2003. doi:10.1159/000074898.
Svegliati-Baroni G.; Candelaresi C.; Saccomanno S. et al. A model of insulin resistance and nonalcoholic steatohepatitis in rats. Role of peroxisome proliferators-activated receptor-α and n−3 polyunsaturated fatty acid treatment on liver injury. Am J Pathol. 169: 846–860; 2006. doi:10.2353/ajpath.2006.050953.
Teran-Garcia M.; Adamson A. W.; Yu G. et al. Polyunsaturated fatty acids suppression by fatty acid synthase (FASN): evidence for dietary modulation of NF-Y binding to the Fasn promoter by SREBP-1c. Biochem J. 402: 591–600; 2007. doi:10.1042/BJ20061722.
Vinciguerra M.; Veyrat-Durebex C.; Moukil M. A. et al. PTEN down-regulation by unsaturated fatty acids triggers hepatic steatosis via an NFκBp65/mTOR-dependent mechanism. Gastroenterology. 134: 268–280; 2008. doi:10.1053/j.gastro.2007.10.010.
Wendland E.; Farmer A.; Glasziou P.; Neil A. Effect of linolenic acid on cardiovascular risk markers: a systematic review. Heart. 92: 166–169; 2006. doi:10.1136/hrt.2004.053538.
Yahagi N.; Shimano H.; Hasty A. H. et al. Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice. J Biol Chem. 277: 19353–19357; 2002. doi:10.1074/jbc.M201584200.
Yu-Poth S.; Yin D.; Kris-Etherton P. M. et al. Long-chain polyunsaturated fatty acids upregulate LDL receptor protein expression in fibroblasts and HepG2 cells. J Nutr. 135: 2541–2545; 2005.
Acknowledgements
This work was supported in part by the research fund of the Daiwa Securities Health Foundation (Japan), Clinical Research Foundation (Japan), and Institute of Kampo Medicine (Japan).
Author information
Authors and Affiliations
Corresponding author
Additional information
Editor: J. Denry Sato
Rights and permissions
About this article
Cite this article
Kohjima, M., Enjoji, M., Higuchi, N. et al. The effects of unsaturated fatty acids on lipid metabolism in HepG2 cells. In Vitro Cell.Dev.Biol.-Animal 45, 6–9 (2009). https://doi.org/10.1007/s11626-008-9144-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11626-008-9144-7